China SXT Pharmaceuticals (SXTC) Short Interest Ratio & Short Volume $2.22 -0.12 (-5.13%) Closing price 04:00 PM EasternExtended Trading$2.24 +0.02 (+0.90%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock China SXT Pharmaceuticals Short Interest DataChina SXT Pharmaceuticals (SXTC) has a short interest of 51,300 shares, representing 0.37% of the float (the number of shares available for trading by the public). This marks a -2.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 958,990 shares to cover all short positions.Current Short Interest51,300 sharesPrevious Short Interest52,700 sharesChange Vs. Previous Month-2.66%Dollar Volume Sold Short$87,210.00Short Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares723,000 sharesFloat Size13,730,000 sharesShort Percent of Float0.37%Today's Trading Volume205,008 sharesAverage Trading Volume958,990 sharesToday's Volume Vs. Average21% Short Selling China SXT Pharmaceuticals? Sign up to receive the latest short interest report for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSXTC Short Interest Over TimeSXTC Days to Cover Over TimeSXTC Percentage of Float Shorted Over Time China SXT Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202551,300 shares $87,210.00 -2.7%0.4%0 $1.70 3/31/202552,700 shares $133,067.50 +60.2%0.4%0.6 $2.53 3/15/202532,900 shares $92,778.00 -54.8%0.2%0.3 $2.82 2/28/202572,800 shares $328,328.00 +1,448.9%3.2%0.4 $4.51 2/15/20254,700 shares $14,363.20 -95.0%0.1%0 $3.06 1/31/202594,100 shares $38,581.00 +129.0%2.7%0.1 $0.41 1/15/202541,100 shares $16,135.86 -89.1%1.2%0 $0.39 12/31/2024377,600 shares $191,858.56 +44.1%11.0%0.4 $0.51 12/15/2024262,000 shares $100,870.00 +263.4%7.6%0.3 $0.39 11/30/202472,100 shares $28,840.00 +7.6%2.1%0.1 $0.40 Get the Latest News and Ratings for SXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/202467,000 shares $25,935.03 -36.4%2.0%0.1 $0.39 10/31/2024105,300 shares $58,862.70 -46.3%3.1%0.2 $0.56 10/15/2024196,000 shares $123,970.00 -22.1%5.7%0.3 $0.63 9/30/2024251,600 shares $183,617.68 -44.7%7.3%0.3 $0.73 9/15/2024455,300 shares $303,229.80 +744.7%13.1%0.7 $0.67 8/31/202453,900 shares $33,886.93 +32.8%1.6%0.1 $0.63 8/15/202440,600 shares $41,818.00 -23.3%1.2%0.1 $1.03 7/31/202452,900 shares $58,719.00 -68.2%7.6%0.1 $1.11 7/15/2024166,100 shares $195,998.00 +347.7%24.0%0.3 $1.18 6/30/202437,100 shares $40,439.00 -25.1%5.4%0 $1.09 6/15/202449,500 shares $54,450.00 +43.1%9.3%0 $1.10 5/31/202434,600 shares $36,343.84 +76.5%6.5%0 $1.05 5/15/202419,600 shares $21,364.00 +36.1%3.6%0 $1.09 4/30/202414,400 shares $15,264.00 -77.4%2.6%0 $1.06 4/15/202463,600 shares $74,412.00 +142.8%11.6%0.1 $1.17 3/31/202426,200 shares $44,016.00 +376.4%4.8%0 $1.68 3/15/20245,500 shares $9,570.00 -93.4%1.0%0 $1.74 2/29/202482,800 shares $163,116.00 +145.0%15.1%0.1 $1.97 2/15/202433,800 shares $73,684.00 -59.3%6.2%0 $2.18 1/31/202483,000 shares $161,020.00 +538.5%14.8%0.1 $1.94 1/15/202413,000 shares $24,440.00 +100.0%2.3%0 $1.88 12/31/20236,500 shares $25,805.00 -67.3%1.2%0 $3.97 12/15/202319,900 shares $38,805.00 -33.7%3.6%0.1 $1.95 11/30/202330,000 shares $63,600.00 +67.6%5.3%0.2 $2.12 11/15/202317,900 shares $42,602.00 -70.2%3.2%0.1 $2.38 10/31/202360,100 shares $129,221.01 -21.4%10.7%0.3 $2.15 10/15/202376,500 shares $225,675.00 +948.0%13.6%0.3 $2.95 9/30/20237,300 shares $22,447.50 -98.7%0.1%0 $3.08 9/15/2023575,400 shares $75,780.18 +99.7%4.6%0.1 $0.13 8/31/2023288,100 shares $32,555.30 +553.3%2.4%0.1 $0.11The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 8/15/202344,100 shares $6,513.57 -61.1%0.4%0 $0.15 7/31/2023113,300 shares $23,113.20 +18.1%1.0%0.2 $0.20 7/15/202395,900 shares $18,796.40 -8.2%1.1%0.1 $0.20 6/30/2023104,500 shares $24,557.50 +5.9%1.2%0.1 $0.24 6/15/202398,700 shares $23,737.35 +4.0%1.2%0.1 $0.24 5/31/202394,900 shares $19,255.21 -69.1%1.1%0.2 $0.20 5/15/2023307,300 shares $69,019.27 +1,034.0%3.6%0.5 $0.22 4/30/202327,100 shares $6,720.80 +942.3%0.3%0 $0.25 4/15/20232,600 shares $621.14 -83.5%0.1%0 $0.24 3/31/202315,800 shares $4,480.88 +13.7%0.5%0 $0.28 3/15/202313,900 shares $4,075.48 -68.3%0.5%0 $0.29 2/28/202343,800 shares $17,182.74 -25.5%1.4%0.1 $0.39 2/15/202358,800 shares $28,812.00 -18.0%1.8%0.1 $0.49 1/31/202371,700 shares $40,144.83 -10.7%2.3%0.1 $0.56 1/15/202380,300 shares $47,377.00 -22.8%1.7%0.1 $0.59 12/30/2022104,000 shares $56,368.00 -68.0%2.2%0.2 $0.54 12/15/2022324,500 shares $195,803.30 +587.5%7.6%0.6 $0.60 11/30/202247,200 shares $33,035.28 +193.2%2.2%0.1 $0.70 11/15/202216,100 shares $10,787.00 -17.0%0.7%0 $0.67 10/31/202219,400 shares $11,640.00 -62.4%0.9%0 $0.60 10/15/202251,600 shares $35,088.00 -16.9%2.4%0.1 $0.68 9/30/202262,100 shares $47,817.00 -50.2%2.8%0.1 $0.77 9/15/2022124,600 shares $139,552.00 -11.3%5.7%0.3 $1.12 8/31/2022140,400 shares $197,262.00 +345.7%6.4%0.3 $1.41 8/15/202231,500 shares $51,345.00 +34.6%1.3%0.2 $1.63 7/31/202223,400 shares $34,164.00 -67.1%1.0%0.2 $1.46 7/15/202271,100 shares $129,402.00 +17.5%4.1%0.7 $1.82 6/30/202260,500 shares $105,875.00 -38.3%3.5%0.6 $1.75 6/15/202298,100 shares $162,846.00 +42.4%5.6%0.3 $1.66 5/31/202268,900 shares $144,690.00 +98.0%4.0%0.2 $2.10 5/15/202234,800 shares $115,118.40 -95.9%2.0%0.1 $3.31 4/30/2022856,400 shares $183,440.88 +7.5%N/A0.1 $0.21 4/15/2022796,400 shares $175,208.00 -84.4%N/A0.1 $0.22 3/31/20225,100,000 shares $1.43 million +1,933.5%38.7%0.5 $0.28 3/15/2022250,800 shares $42,134.40 +19.0%1.9%0 $0.17 2/28/2022210,800 shares $45,954.40 -56.7%1.6%0 $0.22 2/15/2022487,200 shares $89,157.60 -34.7%3.7%0.2 $0.18 1/31/2022746,200 shares $160,656.86 +294.6%5.7%0.3 $0.22 1/15/2022189,100 shares $101,735.80 -32.3%1.4%0.1 $0.54 12/31/2021279,200 shares $181,563.76 +50.6%2.3%0.5 $0.65 12/15/2021185,400 shares $119,564.46 -47.3%1.5%0.4 $0.64 11/30/2021351,800 shares $248,529.46 -31.1%2.9%0.7 $0.71 11/15/2021510,500 shares $433,925.00 -16.6%4.1%1.1 $0.85 10/29/2021612,000 shares $581,767.20 +107.0%5.0%1.3 $0.95 10/15/2021295,600 shares $275,114.92 -18.4%2.4%0.6 $0.93 9/30/2021362,300 shares $373,169.00 -24.4%2.9%0.2 $1.03 9/15/2021479,400 shares $498,576.00 -10.0%3.9%0.2 $1.04 8/31/2021532,900 shares $623,493.00 -3.0%4.3%0.2 $1.17 8/13/2021549,200 shares $648,056.00 -18.8%4.4%0.2 $1.18 7/30/2021675,900 shares $844,875.00 +38.9%5.1%0.3 $1.25The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 7/15/2021486,600 shares $729,900.00 -19.5%3.6%0.2 $1.50 6/30/2021604,700 shares $876,815.00 +19.2%4.5%2.5 $1.45 6/15/2021507,300 shares $715,293.00 -5.0%3.8%1.4 $1.41 5/28/2021533,900 shares $688,731.00 -3.2%4.0%0.9 $1.29 5/14/2021551,400 shares $634,110.00 +2.9%4.1%0.8 $1.15 4/30/2021536,100 shares $771,984.00 -19.7%4.0%0.5 $1.44 4/15/2021667,500 shares $987,900.00 +25.5%5.0%0.4 $1.48 3/31/2021531,700 shares $988,962.00 +21.1%4.0%0.2 $1.86 3/15/2021438,900 shares $877,800.00 +34.1%3.3%0.2 $2.00 2/26/2021327,300 shares $680,784.00 -77.3%2.4%0.1 $2.08 2/12/20211,440,000 shares $1.48 million +15.2%N/A0.6 $1.03 1/29/20211,250,000 shares $841,750.00 +15.7%N/A0.2 $0.67 1/15/20211,080,000 shares $683,532.00 +38.2%N/A0.2 $0.63 12/31/2020781,700 shares $269,686.50 +334.5%N/A0.2 $0.35 12/15/2020179,900 shares $55,265.28 +32.4%N/A0.1 $0.31 11/30/2020135,900 shares $40,076.91 +27.5%N/A0 $0.29 11/15/2020106,600 shares $27,982.50 -78.7%N/A0.1 $0.26 10/30/2020500,400 shares $146,367.00 +220.8%N/A0.2 $0.29 10/15/2020156,000 shares $42,057.60 +24.2%N/A0.1 $0.27 9/30/2020125,600 shares $30,746.88 -81.3%N/A0 $0.24 9/15/2020671,200 shares $171,558.72 +377.7%N/A0.2 $0.26 8/31/2020140,500 shares $42,178.10 -60.4%N/A0 $0.30 8/14/2020354,600 shares $131,131.08 +158.8%N/A0.1 $0.37 7/31/2020137,000 shares $54,334.20 +2.2%N/A0 $0.40 7/15/2020134,000 shares $58,263.20 -84.3%1.0%0 $0.43 6/30/2020853,600 shares $469,053.20 +723.9%6.3%0.1 $0.55 6/15/2020103,600 shares $46,640.72 -53.8%0.8%0 $0.45 5/29/2020224,200 shares $88,693.52 -73.5%1.7%0.1 $0.40 5/15/2020844,700 shares $372,259.29 +50.1%6.2%0.4 $0.44 SXTC Short Interest - Frequently Asked Questions What is China SXT Pharmaceuticals' current short interest? Short interest is the volume of China SXT Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 51,300 shares of SXTC short. 0.37% of China SXT Pharmaceuticals' shares are currently sold short. Learn More on China SXT Pharmaceuticals' current short interest. What is a good short interest percentage for China SXT Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.37% of China SXT Pharmaceuticals' floating shares are currently sold short. Is China SXT Pharmaceuticals' short interest increasing or decreasing? China SXT Pharmaceuticals saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 51,300 shares, a decline of 2.7% from the previous total of 52,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is China SXT Pharmaceuticals' float size? China SXT Pharmaceuticals currently has issued a total of 723,000 shares. Some of China SXT Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China SXT Pharmaceuticals currently has a public float of 13,730,000 shares. How does China SXT Pharmaceuticals' short interest compare to its competitors? 0.37% of China SXT Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to China SXT Pharmaceuticals: Omega Therapeutics, Inc. (26.99%), Lipella Pharmaceuticals Inc. (0.91%), Aytu BioPharma, Inc. (1.98%), Avalon GloboCare Corp. (5.02%), Sonoma Pharmaceuticals, Inc. (3.31%), GT Biopharma, Inc. (2.27%), NLS Pharmaceutics Ltd. (1.87%), Soligenix, Inc. (5.63%), Onconetix, Inc. (3.45%), Aptorum Group Limited (1.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short China SXT Pharmaceuticals stock? Short selling SXTC is an investing strategy that aims to generate trading profit from China SXT Pharmaceuticals as its price is falling. SXTC shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against China SXT Pharmaceuticals? A short squeeze for China SXT Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTC, which in turn drives the price of the stock up even further. How often is China SXT Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTC, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Omega Therapeutics Short Interest Lipella Pharmaceuticals Short Interest Aytu BioPharma Short Interest Avalon GloboCare Short Interest Sonoma Pharmaceuticals Short Interest GT Biopharma Short Interest NLS Pharmaceutics Short Interest Soligenix Short Interest Onconetix Short Interest Aptorum Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SXTC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SXTC Stock Free SXTC Stock Alerts